Tech Company Financing Transactions
Vantis Funding Round
On 3/12/2025, Vantis landed $11 million in Series A funding from Angelini Ventures, b2venture and Bayern Kapital.
Transaction Overview
Company Name
Announced On
3/12/2025
Transaction Type
Venture Equity
Amount
$11,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to continue developing its data-driven, proactive approach to chronic disease management, as well as to expand its team and enhance its use of telemedicine, continuous monitoring, digital therapies, and AI-powered processes.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
Widenmayerstrasse 18
Munich, 80538
Germany
Munich, 80538
Germany
Phone
Website
Email Address
Overview
Every person with a chronic illness should receive the best possible care. That's why we at Vantis focus on holistic solutions that simply work for patients. On-site at the doctor's office as well as digitally at home.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Till Jansen
Browse more venture capital transactions:
Prev: 3/12/2025: elea venture capital transaction
Next: 3/12/2025: eBrands venture capital transaction
Share this article
About Our VC Transactions Data
We document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs